Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SRC family comprises non-receptor tyrosine kinases, with c-Src (SRC) as its prototype. These kinases regulate proliferation, differentiation, survival, migration, and angiogenesis. Aberrant activation or overexpression of c-Src is implicated in many cancers. Inhibitors targeting these kinases are under investigation for therapeutic use.
Inhibition of tyrosine kinase activity of SFKs, preventing phosphorylation of downstream targets and disrupting signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRC Proto-oncogene Non-receptor Tyrosine Kinase Family.